The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference
Virus-like particles (VLPs) and nano-particles (NPs) are promising vaccine platforms that have led to the successful development of commercially available vaccines. The 5th international virus-like particle and nano-particle vaccines conference was held in Bern, Switzerland, from the 25th to the 27t...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2019-01-01
|
| Series: | Expert Review of Vaccines |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/14760584.2019.1557522 |
| _version_ | 1827813214770954240 |
|---|---|
| author | Paul Engeroff Martin F. Bachmann |
| author_facet | Paul Engeroff Martin F. Bachmann |
| author_sort | Paul Engeroff |
| collection | DOAJ |
| description | Virus-like particles (VLPs) and nano-particles (NPs) are promising vaccine platforms that have led to the successful development of commercially available vaccines. The 5th international virus-like particle and nano-particle vaccines conference was held in Bern, Switzerland, from the 25th to the 27th of September in 2018. Topics included novel vaccine production techniques, methods to enhance vaccine immunogenicity, and preclinical/clinical efficacy evaluation of vaccine candidates. Here, we report on a selection of updates that were presented including the production of vaccines in plants, novel adjuvants to enhance vaccine immunogenicity, novel techniques of conjugating vaccine platforms with target antigens and the use of VLP-based vaccines for cancer and inflammatory diseases. |
| first_indexed | 2024-03-11T23:28:39Z |
| format | Article |
| id | doaj.art-337e845491e642599fa0e728b001c283 |
| institution | Directory Open Access Journal |
| issn | 1476-0584 1744-8395 |
| language | English |
| last_indexed | 2024-03-11T23:28:39Z |
| publishDate | 2019-01-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Expert Review of Vaccines |
| spelling | doaj.art-337e845491e642599fa0e728b001c2832023-09-20T10:18:04ZengTaylor & Francis GroupExpert Review of Vaccines1476-05841744-83952019-01-011811310.1080/14760584.2019.15575221557522The 5th virus-like particle and nano-particle vaccines (VLPNPV) conferencePaul Engeroff0Martin F. Bachmann1University Hospital Bern, University of BernUniversity Hospital Bern, University of BernVirus-like particles (VLPs) and nano-particles (NPs) are promising vaccine platforms that have led to the successful development of commercially available vaccines. The 5th international virus-like particle and nano-particle vaccines conference was held in Bern, Switzerland, from the 25th to the 27th of September in 2018. Topics included novel vaccine production techniques, methods to enhance vaccine immunogenicity, and preclinical/clinical efficacy evaluation of vaccine candidates. Here, we report on a selection of updates that were presented including the production of vaccines in plants, novel adjuvants to enhance vaccine immunogenicity, novel techniques of conjugating vaccine platforms with target antigens and the use of VLP-based vaccines for cancer and inflammatory diseases.http://dx.doi.org/10.1080/14760584.2019.1557522virus-like particlesnano-particlesvaccinesimmunogenicityinflammationcancer |
| spellingShingle | Paul Engeroff Martin F. Bachmann The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference Expert Review of Vaccines virus-like particles nano-particles vaccines immunogenicity inflammation cancer |
| title | The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference |
| title_full | The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference |
| title_fullStr | The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference |
| title_full_unstemmed | The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference |
| title_short | The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference |
| title_sort | 5th virus like particle and nano particle vaccines vlpnpv conference |
| topic | virus-like particles nano-particles vaccines immunogenicity inflammation cancer |
| url | http://dx.doi.org/10.1080/14760584.2019.1557522 |
| work_keys_str_mv | AT paulengeroff the5thviruslikeparticleandnanoparticlevaccinesvlpnpvconference AT martinfbachmann the5thviruslikeparticleandnanoparticlevaccinesvlpnpvconference AT paulengeroff 5thviruslikeparticleandnanoparticlevaccinesvlpnpvconference AT martinfbachmann 5thviruslikeparticleandnanoparticlevaccinesvlpnpvconference |